tiprankstipranks
MediPharm Labs (TSE:LABS)
TSX:LABS

MediPharm Labs (LABS) Income Statement

153 Followers

MediPharm Labs Income Statement

Last quarter (Q1 2024), MediPharm Labs's total revenue was C$9.77M, an increase of 67.23% from the same quarter last year. In Q1, MediPharm Labs's net income was C$-3.61M. See MediPharm Labs’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
C$ 36.99MC$ 33.06MC$ 177.00KC$ 21.71MC$ 36.01MC$ 129.25M
Cost of Revenue
C$ 28.23MC$ 27.21MC$ 24.03MC$ 36.96MC$ 79.99MC$ 86.34M
Gross Profit
C$ 9.48MC$ 5.86MC$ -23.85MC$ -15.25MC$ -43.98MC$ 42.91M
Operating Expense
C$ 19.30MC$ 23.60MC$ 31.05MC$ 27.76MC$ 27.74MC$ 35.08M
Operating Income
C$ -15.86MC$ -17.75MC$ -54.91MC$ -43.01MC$ -71.71MC$ 7.83M
Net Non Operating Interest Income Expense
C$ -606.00KC$ -475.00KC$ 448.00KC$ 10.28MC$ -7.60MC$ -186.00K
Other Income Expense
C$ 6.24MC$ 3.91MC$ -26.00KC$ -1.40MC$ 7.22MC$ -893.00K
Pretax Income
C$ -13.88MC$ -13.36MC$ -54.17MC$ -54.69MC$ -72.10MC$ 6.75M
Tax Provision
C$ -276.00KC$ -276.00KC$ -6.00KC$ 113.00KC$ -4.99MC$ 5.62M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
C$ -13.61MC$ -13.08MC$ -54.16MC$ -54.80MC$ -66.35MC$ 1.65M
Basic EPS
C$ -0.04C$ -0.04C$ -110.00C$ -0.22C$ -0.48C$ 0.01
Diluted EPS
C$ -0.04C$ -0.04C$ -110.00C$ -0.22C$ -0.48C$ 0.01
Basic Average Shares
C$ 1.55BC$ 363.32MC$ 276.86BC$ 249.91MC$ 138.55MC$ 120.00M
Diluted Average Shares
C$ 1.55BC$ 363.32MC$ 276.86BC$ 249.91MC$ 138.55MC$ 134.63M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
----C$ 709.00K-
Total Expenses
C$ 30.07MC$ 50.81M-C$ -64.72MC$ 107.73MC$ 121.42M
Net Income From Continuing And Discontinued Operation
C$ -13.61MC$ -13.08MC$ -54.16MC$ -54.80MC$ -66.35MC$ 1.65M
Normalized Income
C$ -9.89MC$ -13.59MC$ -54.17MC$ -35.95MC$ -73.07MC$ 2.30M
Interest Expense
----C$ 7.88MC$ 435.00K
EBIT
C$ -10.28MC$ -12.99MC$ -54.14MC$ -44.18MC$ -64.22MC$ 7.19M
EBITDA
C$ -8.79MC$ -10.48MC$ -53.31MC$ -38.55MC$ -53.42MC$ 9.72M
Currency in CAD

MediPharm Labs Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis